A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis

NCT03365869 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Sirolimus

Sponsor

Peking University People's Hospital